Filing Details
- Accession Number:
- 0001209191-19-016381
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-05 16:04:05
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-05 16:04:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1439222 | Agios Pharmaceuticals Inc | AGIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1533451 | L. Steven Hoerter | C/O Agios Pharmaceuticals 88 Sidney Street Cambridge MA 02139 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-01 | 5,000 | $39.76 | 15,941 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-01 | 5,000 | $66.01 | 10,941 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-03-04 | 5,000 | $39.76 | 15,941 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-04 | 5,000 | $68.00 | 10,941 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2019-03-01 | 5,000 | $0.00 | 5,000 | $39.76 |
| Common Stock | Stock option (right to buy) | Disposition | 2019-03-04 | 5,000 | $0.00 | 5,000 | $39.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 55,650 | 2026-02-15 | No | 4 | M | Direct | |
| 50,650 | 2026-02-15 | No | 4 | M | Direct |
Footnotes
- This option was granted on February 16, 2016. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
